Who to call at AYTU BIOPHARMA, INC., and when
Fundz watches for the moments AYTU BIOPHARMA, INC. starts buying, and tells you who to reach.
- An alert the day AYTU BIOPHARMA, INC. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AYTU BIOPHARMA, INC., from your own LinkedIn network
AYTU BIOPHARMA, INC.
The company released its quarterly or annual results. An 8-K is the notice a US public company must file within four business days of a major event.
aytubio.comAI Executive Summary
AI-powered analysis of 8-K filing content
Aytu BioPharma announced its fiscal 2026 fourth quarter operational and financial results on September 22, 2026, via press release and public conference call, providing transparency on company performance and strategic initiatives.
Key Takeaways
Company released Q4 fiscal 2026 results demonstrating operational and financial performance for the latest quarter
Public conference call scheduled for 4:30 p.m. Eastern time on the same day to discuss results and address shareholder inquiries
1 more takeaway
Related Filings (1)
1 more filing from AYTU BIOPHARMA, INC. in the last 90 days
Filing Overview
What This Means
AYTU BIOPHARMA, INC. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.